Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Frontage Holdings Corp

1521
Current price
1.05 HKD +0.02 HKD (+1.94%)
Last closed 1.04 HKD
ISIN KYG3679P1019
Sector Healthcare
Industry Biotechnology
Exchange Hong Kong Stock Exchange
Capitalization 1 927 566 002 HKD
Yield for 12 month -47.24 %
1Y
3Y
5Y
10Y
15Y
1521
21.11.2021 - 28.11.2021

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services. The company also provides early stage clinical/bioequivalence services; absolute bioavailability and human radiolabel studies; and chemistry services, including performing custom synthesis. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited. Address: 700 Pennsylvania Drive, Exton, PA, United States, 19341

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.07 HKD

P/E ratio

48.5

Dividend Yield

Current Year

+2 022 780 182 HKD

Last Year

+1 948 868 585 HKD

Current Quarter

+999 157 118 HKD

Last Quarter

Current Year

+610 239 670 HKD

Last Year

+694 309 732 HKD

Current Quarter

+303 492 924 HKD

Last Quarter

Key Figures 1521

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 41 226 503 HKD
Operating Margin TTM 2.09 %
PE Ratio 48.5
Return On Assets TTM 1.63 %
PEG Ratio
Return On Equity TTM 1.74 %
Wall Street Target Price 12.07 HKD
Revenue TTM 260 267 560 HKD
Book Value 0.17 HKD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 0.1 %
Dividend Yield
Gross Profit TTM 89 294 717 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter II 2023
Quarterly Earnings Growth YOY -51.6 %
Profit Margin 2.35 %

Dividend Analytics 1521

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 1521

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 1521

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 48.5
Forward PE 28.9855
Enterprise Value Revenue 1.372
Price Sales TTM 7.4061
Enterprise Value EBITDA 22.5409
Price Book MRQ 0.7392

Financials 1521

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 1521

For 52 weeks

0.47 HKD 2.33 HKD
50 Day MA 0.7 HKD
Shares Short Prior Month
200 Day MA 1.1 HKD
Short Ratio
Shares Short
Short Percent